Holds 2 active US DMFs and 2 valid CEPs for metoprolol, filing since 2006. Its 2025 FDA inspection closed as NAI.
Holds one valid CEP for metoprolol, filing since 2024. Its 2025 FDA inspection closed as NAI.
Holds one active US DMF for metoprolol, filing since 2014. Its GMP is recognised in 4 markets.
Holds 2 active US DMFs for metoprolol, filing since 2014. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF and one valid CEP for metoprolol, filing since 2013. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 1 market.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Metoprolol manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free